| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 12 |
| GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: Q4Q231
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0002943 | tRNA dihydrouridine synthesis | 7 | 2 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
| GO:0006396 | RNA processing | 6 | 2 |
| GO:0006399 | tRNA metabolic process | 7 | 2 |
| GO:0006400 | tRNA modification | 6 | 2 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0008033 | tRNA processing | 8 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009451 | RNA modification | 5 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016070 | RNA metabolic process | 5 | 2 |
| GO:0034470 | ncRNA processing | 7 | 2 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
| GO:0034660 | ncRNA metabolic process | 6 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0043412 | macromolecule modification | 4 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0046483 | heterocycle metabolic process | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0090304 | nucleic acid metabolic process | 4 | 2 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 11 |
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0005488 | binding | 1 | 11 |
| GO:0016491 | oxidoreductase activity | 2 | 11 |
| GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 11 |
| GO:0017150 | tRNA dihydrouridine synthase activity | 5 | 11 |
| GO:0036094 | small molecule binding | 2 | 11 |
| GO:0043167 | ion binding | 2 | 11 |
| GO:0043168 | anion binding | 3 | 11 |
| GO:0050660 | flavin adenine dinucleotide binding | 4 | 11 |
| GO:0097159 | organic cyclic compound binding | 2 | 11 |
| GO:0106413 | dihydrouridine synthase activity | 4 | 11 |
| GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
| GO:0140101 | catalytic activity, acting on a tRNA | 4 | 11 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
| GO:1901265 | nucleoside phosphate binding | 3 | 11 |
| GO:1901363 | heterocyclic compound binding | 2 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 283 | 287 | PF00656 | 0.541 |
| CLV_NRD_NRD_1 | 313 | 315 | PF00675 | 0.277 |
| CLV_NRD_NRD_1 | 423 | 425 | PF00675 | 0.650 |
| CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.709 |
| CLV_PCSK_FUR_1 | 4 | 8 | PF00082 | 0.473 |
| CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.360 |
| CLV_PCSK_KEX2_1 | 197 | 199 | PF00082 | 0.269 |
| CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.474 |
| CLV_PCSK_KEX2_1 | 425 | 427 | PF00082 | 0.708 |
| CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.245 |
| CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.360 |
| CLV_PCSK_PC1ET2_1 | 197 | 199 | PF00082 | 0.305 |
| CLV_PCSK_PC1ET2_1 | 425 | 427 | PF00082 | 0.708 |
| CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.255 |
| CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.332 |
| CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.341 |
| CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.295 |
| CLV_PCSK_SKI1_1 | 345 | 349 | PF00082 | 0.380 |
| CLV_PCSK_SKI1_1 | 355 | 359 | PF00082 | 0.384 |
| CLV_PCSK_SKI1_1 | 373 | 377 | PF00082 | 0.529 |
| CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.337 |
| CLV_Separin_Metazoa | 259 | 263 | PF03568 | 0.560 |
| CLV_Separin_Metazoa | 68 | 72 | PF03568 | 0.393 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.698 |
| DEG_SCF_FBW7_2 | 75 | 81 | PF00400 | 0.560 |
| DEG_SPOP_SBC_1 | 447 | 451 | PF00917 | 0.511 |
| DOC_CKS1_1 | 226 | 231 | PF01111 | 0.533 |
| DOC_CKS1_1 | 75 | 80 | PF01111 | 0.560 |
| DOC_CKS1_1 | 98 | 103 | PF01111 | 0.481 |
| DOC_CYCLIN_RxL_1 | 342 | 351 | PF00134 | 0.426 |
| DOC_CYCLIN_yCln2_LP_2 | 98 | 104 | PF00134 | 0.505 |
| DOC_MAPK_gen_1 | 194 | 203 | PF00069 | 0.457 |
| DOC_MAPK_gen_1 | 4 | 12 | PF00069 | 0.465 |
| DOC_MAPK_HePTP_8 | 191 | 203 | PF00069 | 0.527 |
| DOC_MAPK_MEF2A_6 | 120 | 127 | PF00069 | 0.542 |
| DOC_MAPK_MEF2A_6 | 194 | 203 | PF00069 | 0.439 |
| DOC_MAPK_MEF2A_6 | 4 | 12 | PF00069 | 0.465 |
| DOC_MAPK_NFAT4_5 | 120 | 128 | PF00069 | 0.541 |
| DOC_PP1_RVXF_1 | 343 | 350 | PF00149 | 0.484 |
| DOC_USP7_MATH_1 | 184 | 188 | PF00917 | 0.544 |
| DOC_USP7_MATH_1 | 320 | 324 | PF00917 | 0.573 |
| DOC_USP7_MATH_1 | 431 | 435 | PF00917 | 0.702 |
| DOC_USP7_UBL2_3 | 89 | 93 | PF12436 | 0.455 |
| DOC_WW_Pin1_4 | 225 | 230 | PF00397 | 0.513 |
| DOC_WW_Pin1_4 | 240 | 245 | PF00397 | 0.404 |
| DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.567 |
| DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.560 |
| DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.481 |
| LIG_14-3-3_CanoR_1 | 115 | 119 | PF00244 | 0.393 |
| LIG_14-3-3_CanoR_1 | 198 | 204 | PF00244 | 0.466 |
| LIG_14-3-3_CanoR_1 | 353 | 358 | PF00244 | 0.470 |
| LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.630 |
| LIG_AP2alpha_2 | 86 | 88 | PF02296 | 0.505 |
| LIG_APCC_ABBA_1 | 375 | 380 | PF00400 | 0.523 |
| LIG_BRCT_BRCA1_1 | 36 | 40 | PF00533 | 0.560 |
| LIG_FHA_1 | 24 | 30 | PF00498 | 0.258 |
| LIG_FHA_1 | 410 | 416 | PF00498 | 0.605 |
| LIG_FHA_1 | 52 | 58 | PF00498 | 0.507 |
| LIG_FHA_1 | 93 | 99 | PF00498 | 0.505 |
| LIG_FHA_2 | 397 | 403 | PF00498 | 0.487 |
| LIG_GBD_Chelix_1 | 199 | 207 | PF00786 | 0.341 |
| LIG_LIR_Gen_1 | 356 | 365 | PF02991 | 0.401 |
| LIG_LIR_Gen_1 | 391 | 400 | PF02991 | 0.458 |
| LIG_LIR_Nem_3 | 267 | 273 | PF02991 | 0.537 |
| LIG_LIR_Nem_3 | 346 | 352 | PF02991 | 0.375 |
| LIG_LIR_Nem_3 | 356 | 361 | PF02991 | 0.333 |
| LIG_LIR_Nem_3 | 366 | 372 | PF02991 | 0.201 |
| LIG_LIR_Nem_3 | 37 | 43 | PF02991 | 0.536 |
| LIG_LIR_Nem_3 | 391 | 396 | PF02991 | 0.412 |
| LIG_LIR_Nem_3 | 81 | 85 | PF02991 | 0.452 |
| LIG_LYPXL_yS_3 | 72 | 75 | PF13949 | 0.541 |
| LIG_PCNA_PIPBox_1 | 341 | 350 | PF02747 | 0.466 |
| LIG_PTB_Apo_2 | 357 | 364 | PF02174 | 0.478 |
| LIG_PTB_Phospho_1 | 357 | 363 | PF10480 | 0.482 |
| LIG_SH2_CRK | 354 | 358 | PF00017 | 0.393 |
| LIG_SH2_NCK_1 | 254 | 258 | PF00017 | 0.466 |
| LIG_SH2_STAP1 | 254 | 258 | PF00017 | 0.466 |
| LIG_SH2_STAP1 | 339 | 343 | PF00017 | 0.534 |
| LIG_SH2_STAP1 | 350 | 354 | PF00017 | 0.309 |
| LIG_SH2_STAP1 | 389 | 393 | PF00017 | 0.375 |
| LIG_SH2_STAT3 | 108 | 111 | PF00017 | 0.393 |
| LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.516 |
| LIG_SH3_3 | 124 | 130 | PF00018 | 0.481 |
| LIG_SH3_3 | 226 | 232 | PF00018 | 0.525 |
| LIG_SH3_3 | 32 | 38 | PF00018 | 0.541 |
| LIG_SH3_3 | 67 | 73 | PF00018 | 0.541 |
| LIG_SH3_3 | 98 | 104 | PF00018 | 0.534 |
| LIG_SUMO_SIM_anti_2 | 412 | 418 | PF11976 | 0.489 |
| LIG_SUMO_SIM_par_1 | 8 | 14 | PF11976 | 0.451 |
| LIG_SUMO_SIM_par_1 | 94 | 100 | PF11976 | 0.505 |
| LIG_TRAF2_1 | 399 | 402 | PF00917 | 0.404 |
| LIG_TRAF2_1 | 433 | 436 | PF00917 | 0.681 |
| LIG_TYR_ITIM | 352 | 357 | PF00017 | 0.479 |
| LIG_TYR_ITIM | 70 | 75 | PF00017 | 0.541 |
| MOD_CDK_SPxxK_3 | 240 | 247 | PF00069 | 0.541 |
| MOD_CDK_SPxxK_3 | 34 | 41 | PF00069 | 0.560 |
| MOD_CK1_1 | 202 | 208 | PF00069 | 0.484 |
| MOD_CK1_1 | 225 | 231 | PF00069 | 0.484 |
| MOD_CK1_1 | 280 | 286 | PF00069 | 0.466 |
| MOD_CK2_1 | 186 | 192 | PF00069 | 0.477 |
| MOD_CK2_1 | 396 | 402 | PF00069 | 0.428 |
| MOD_Cter_Amidation | 195 | 198 | PF01082 | 0.298 |
| MOD_DYRK1A_RPxSP_1 | 34 | 38 | PF00069 | 0.560 |
| MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.346 |
| MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.385 |
| MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.653 |
| MOD_GSK3_1 | 114 | 121 | PF00069 | 0.546 |
| MOD_GSK3_1 | 207 | 214 | PF00069 | 0.454 |
| MOD_GSK3_1 | 405 | 412 | PF00069 | 0.541 |
| MOD_GSK3_1 | 427 | 434 | PF00069 | 0.701 |
| MOD_GSK3_1 | 447 | 454 | PF00069 | 0.707 |
| MOD_GSK3_1 | 88 | 95 | PF00069 | 0.487 |
| MOD_N-GLC_1 | 277 | 282 | PF02516 | 0.255 |
| MOD_NEK2_1 | 222 | 227 | PF00069 | 0.440 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.428 |
| MOD_NEK2_1 | 277 | 282 | PF00069 | 0.469 |
| MOD_NEK2_1 | 348 | 353 | PF00069 | 0.450 |
| MOD_NEK2_1 | 405 | 410 | PF00069 | 0.489 |
| MOD_NEK2_1 | 88 | 93 | PF00069 | 0.525 |
| MOD_PIKK_1 | 222 | 228 | PF00454 | 0.519 |
| MOD_PK_1 | 155 | 161 | PF00069 | 0.455 |
| MOD_PKA_1 | 155 | 161 | PF00069 | 0.455 |
| MOD_PKA_1 | 314 | 320 | PF00069 | 0.477 |
| MOD_PKA_2 | 114 | 120 | PF00069 | 0.393 |
| MOD_Plk_1 | 104 | 110 | PF00069 | 0.393 |
| MOD_Plk_1 | 18 | 24 | PF00069 | 0.499 |
| MOD_Plk_1 | 211 | 217 | PF00069 | 0.541 |
| MOD_Plk_2-3 | 385 | 391 | PF00069 | 0.500 |
| MOD_Plk_2-3 | 81 | 87 | PF00069 | 0.496 |
| MOD_Plk_4 | 18 | 24 | PF00069 | 0.444 |
| MOD_Plk_4 | 277 | 283 | PF00069 | 0.508 |
| MOD_ProDKin_1 | 225 | 231 | PF00069 | 0.513 |
| MOD_ProDKin_1 | 240 | 246 | PF00069 | 0.404 |
| MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.567 |
| MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.560 |
| MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.481 |
| MOD_SUMO_for_1 | 16 | 19 | PF00179 | 0.477 |
| MOD_SUMO_rev_2 | 283 | 292 | PF00179 | 0.516 |
| TRG_ENDOCYTIC_2 | 354 | 357 | PF00928 | 0.401 |
| TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.387 |
| TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.541 |
| TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.466 |
| TRG_ER_diArg_1 | 3 | 6 | PF00400 | 0.476 |
| TRG_PTS1 | 452 | 455 | PF00515 | 0.494 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P6Z1 | Leptomonas seymouri | 66% | 100% |
| A0A0N1PBT7 | Leptomonas seymouri | 25% | 89% |
| A0A0S4JLG1 | Bodo saltans | 36% | 91% |
| A0A0S4JUA9 | Bodo saltans | 23% | 100% |
| A0A1X0P8K8 | Trypanosomatidae | 46% | 100% |
| A0A3Q8IJ00 | Leishmania donovani | 92% | 100% |
| A0A3R7KZP3 | Trypanosoma rangeli | 26% | 100% |
| A0A422P287 | Trypanosoma rangeli | 47% | 100% |
| A3LUK5 | Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) | 23% | 74% |
| A4HNQ5 | Leishmania braziliensis | 79% | 100% |
| A4ICU0 | Leishmania infantum | 92% | 100% |
| A5DTS1 | Lodderomyces elongisporus (strain ATCC 11503 / CBS 2605 / JCM 1781 / NBRC 1676 / NRRL YB-4239) | 23% | 71% |
| A8NZY7 | Coprinopsis cinerea (strain Okayama-7 / 130 / ATCC MYA-4618 / FGSC 9003) | 24% | 67% |
| D0A2L3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
| E9ASG4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| O74553 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |
| P53720 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
| Q06063 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 21% | 100% |
| Q32M08 | Mus musculus | 25% | 100% |
| Q9D7B1 | Mus musculus | 28% | 92% |
| Q9NX74 | Homo sapiens | 28% | 92% |
| V5DJT2 | Trypanosoma cruzi | 27% | 100% |
| V5DRQ6 | Trypanosoma cruzi | 49% | 100% |